Ziprasidone-associated pedal edema in the treatment of schizophrenia
- PMID: 16624468
- DOI: 10.1016/j.pnpbp.2006.01.020
Ziprasidone-associated pedal edema in the treatment of schizophrenia
Abstract
It has been reported that second generation of antipsychotic drugs may induce pedal edema. The purpose of this case report is to demonstrate that the recently marketed antipsychotic drug, ziprasidone induced pedal edema with an increased plasma immunoglobulin E (IgE) level. A 51-year-old female schizophrenic patient who developed severe pedal edema was treated with ziprasidone for 6 weeks. Admission routine data that included biochemical, blood and urine analysis were normal except for the plasma IgE level, which was significantly elevated. Although the pedal edema subsided after discontinuation of ziprasidone and administration of diuretics, the plasma IgE level remained high. This is the first case report attempting to demonstrate the existence of ziprasidone-induced pedal edema in the treatment of schizophrenia. In this case, the pedal edema was associated with an IgE-related allergic reaction.
Similar articles
-
Switching among antipsychotics in everyday clinical practice: focus on ziprasidone.Postgrad Med. 2011 Jan;123(1):135-59. doi: 10.3810/pgm.2011.01.2255. Postgrad Med. 2011. PMID: 21293094
-
Ziprasidone as a possible cause of cleft palate in a newborn.Psychiatr Danub. 2010 Mar;22(1):117-9. Psychiatr Danub. 2010. PMID: 20305605
-
Effectiveness, safety, and tolerability of ziprasidone for treating schizophrenia patients undergoing usual care: a 12-month, open-label, flexible-dose, naturalistic observational trial.Prog Neuropsychopharmacol Biol Psychiatry. 2007 Oct 1;31(7):1401-9. doi: 10.1016/j.pnpbp.2007.06.008. Epub 2007 Jun 21. Prog Neuropsychopharmacol Biol Psychiatry. 2007. PMID: 17669574 Clinical Trial.
-
Strategies for successful clinical management of schizophrenia with ziprasidone.Expert Opin Pharmacother. 2010 Sep;11(13):2199-220. doi: 10.1517/14656566.2010.507630. Expert Opin Pharmacother. 2010. PMID: 20658947 Review.
-
Tolerability of ziprasidone: an expanding perspective.J Clin Psychiatry. 2003;64 Suppl 19:40-9. J Clin Psychiatry. 2003. PMID: 14728089 Review.
Cited by
-
Immunoendocrine Peripheral Effects Induced by Atypical Antipsychotics.Front Endocrinol (Lausanne). 2020 Apr 21;11:195. doi: 10.3389/fendo.2020.00195. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 32373066 Free PMC article. Review.
-
Bilateral Pretibial Edema Associated with Paliperidone Palmitate Long-acting Injectable: A Case Report.Clin Psychopharmacol Neurosci. 2017 May 31;15(2):184-186. doi: 10.9758/cpn.2017.15.2.184. Clin Psychopharmacol Neurosci. 2017. PMID: 28449568 Free PMC article.
-
3 case reports of edema associated with quetiapine.Ann Clin Psychiatry. 2009 Apr-Jun;21(2):77-80. Ann Clin Psychiatry. 2009. PMID: 19439156 Free PMC article.
-
Self-limiting Atypical Antipsychotics-induced Edema: Clinical Cases and Systematic Review.Indian J Psychol Med. 2016 May-Jun;38(3):182-8. doi: 10.4103/0253-7176.183089. Indian J Psychol Med. 2016. PMID: 27335511 Free PMC article. Review.
-
The Influence of a Xanthine-Catechin Chemical Matrix on in vitro Macrophage-Activation Triggered by Antipsychotic Ziprasidone.Inflammation. 2019 Jun;42(3):915-925. doi: 10.1007/s10753-018-0946-9. Inflammation. 2019. PMID: 30547260
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical